logo |

News

    Home   >     Industry    >     Main body

    J&J reports $100 million in vaccine sales as results top forecasts

    Abstract:(Reuters) -Johnson & Johnson beat expectations for quarterly revenue and profit and raised dividend payouts to shareholders on Tuesday, while reporting $100 million in sales for its COVID-19 vaccine, whose use was paused by U.S. regulators last week.

      The company, which has previously said the vaccine will be available on a not-for-profit basis until the end of the pandemic, also tightened its forecast for adjusted profit this year, showing it largely performed as previously expected.

      Use of the vaccine was paused last week by U.S. regulators as they review reports of rare but serious blood clots in recipients.

      [fx-primis-ad]

      The company now expects full-year adjusted profit of $9.42 to $9.57 per share, compared with its prior forecast of $9.40 to $9.60 per share, after sales in its pharmaceuticals business helped boost overall profit.

      Excluding items, the company earned $2.59 per share, beating analysts estimates of $2.34 per share, according to IBES data from Refinitiv.

      Sales of cancer drug Darzalex rose 45.7% to $1.37 billion and sales of Stelara, a treatment for Crohns disease and plaque psoriasis, rose about 18% to $2.15 billion.

      Net earnings rose nearly 7% to $6.20 billion, or $2.32 per share.

      Sales rose 7.9% to $22.32 billion, beating estimates of $21.98 billion.

      The company also declared an increase in its quarterly dividend to $1.06 per share from $1.01 per share.

      (Reporting by Manas Mishra and Manojna Maddipatla in Bengaluru; Editing by Anil DSilva)

      [fx-article-ad]

    Singapore Dollar

    • United Arab Emirates Dirham
    • Australia Dollar
    • Canadian Dollar
    • Swiss Franc
    • Chinese Yuan
    • Danish Krone
    • Euro
    • British Pound
    • Hong Kong Dollar
    • Hungarian Forint
    • Japanese Yen
    • South Korean Won
    • Mexican Peso
    • Malaysian Ringgit
    • Norwegian Krone
    • New Zealand Dollar
    • Polish Zloty
    • Russian Ruble
    • Saudi Arabian Riyal
    • Swedish Krona
    • Singapore Dollar
    • Thai Baht
    • Turkish Lira
    • United States Dollar
    • South African Rand

    United States Dollar

    • United Arab Emirates Dirham
    • Australia Dollar
    • Canadian Dollar
    • Swiss Franc
    • Chinese Yuan
    • Danish Krone
    • Euro
    • British Pound
    • Hong Kong Dollar
    • Hungarian Forint
    • Japanese Yen
    • South Korean Won
    • Mexican Peso
    • Malaysian Ringgit
    • Norwegian Krone
    • New Zealand Dollar
    • Polish Zloty
    • Russian Ruble
    • Saudi Arabian Riyal
    • Swedish Krona
    • Singapore Dollar
    • Thai Baht
    • Turkish Lira
    • United States Dollar
    • South African Rand
    Current Rate  :
    --
    Amount
    Singapore Dollar
    Available
    -- United States Dollar
    Risk Warning

    The Database of WikiFX comes from the official regulatory authorities , such as the FCA, ASIC, etc. The published content is also based on fairness, objectivity and fact. WikiFX doesn't ask for PR fees, advertising fees, ranking fees, data cleaning fees and other illogical fees. WikiFX will do its utmost to maintain the consistency and synchronization of database with authoritative data sources such as regulatory authorities, but does not guarantee the data to be up to date consistently.

    Given the complexity of forex industry, some brokers are issued legal licenses by cheating regulation institutes. If the data published by WikiFX are not in accordance with the fact, please click 'Complaints 'and 'Correction' to inform us. We will check immediately and release the results.

    Foreign exchange, precious metals and over-the-counter (OTC) contracts are leveraged products, which have high risks and may lead to losses of your investment principal. Please invest rationally.

    Special Note, the content of the Wikifx site is for information purposes only and should not be construed as investment advice. The Forex broker is chosen by the client. The client understands and takes into account all risks arising with Forex trading is not relevant with WikiFX, the client should bear full responsibility for their consequences.